Loss of Usp9x disrupts cortical architecture, hippocampal development and TGFb-mediated axonogenesis by Stegeman, Shane et al.
Loss of Usp9x Disrupts Cortical Architecture,
Hippocampal Development and TGFb-Mediated
Axonogenesis
Shane Stegeman1., Lachlan A. Jolly2,3., Susitha Premarathne1, Jozef Gecz2,3, Linda J. Richards4,
Alan Mackay-Sim1, Stephen A. Wood1*
1 Eskitis Institute for Cell and Molecular Therapies, Griffith University, Brisbane, Queensland, Australia, 2Neurogenetics Research Program, South Australian Pathology at
Women’s and Children’s Hospital, Adelaide, South Australia, Australia, 3 School of Paediatrics and Reproductive Health, The University of Adelaide, Adelaide, South
Australia, Australia, 4Queensland Brain Institute and The School of Biomedical Sciences, The University of Queensland, Brisbane, Queensland, Australia
Abstract
The deubiquitylating enzyme Usp9x is highly expressed in the developing mouse brain, and increased Usp9x expression
enhances the self-renewal of neural progenitors in vitro. USP9X is a candidate gene for human neurodevelopmental
disorders, including lissencephaly, epilepsy and X-linked intellectual disability. To determine if Usp9x is critical to mammalian
brain development we conditionally deleted the gene from neural progenitors, and their subsequent progeny. Mating
Usp9xloxP/loxP mice with mice expressing Cre recombinase from the Nestin promoter deleted Usp9x throughout the entire
brain, and resulted in early postnatal lethality. Although the overall brain architecture was intact, loss of Usp9x disrupted the
cellular organization of the ventricular and sub-ventricular zones, and cortical plate. Usp9x absence also led to dramatic
reductions in axonal length, in vivo and in vitro, which could in part be explained by a failure in Tgf-b signaling. Deletion of
Usp9x from the dorsal telencephalon only, by mating with Emx1-cre mice, was compatible with survival to adulthood but
resulted in reduction or loss of the corpus callosum, a dramatic decrease in hippocampal size, and disorganization of the
hippocampal CA3 region. This latter phenotypic aspect resembled that observed in Doublecortin knock-out mice, which is
an Usp9x interacting protein. This study establishes that Usp9x is critical for several aspects of CNS development, and
suggests that its regulation of Tgf-b signaling extends to neurons.
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Introduction
During embryonic development of the brain, neural cells need
to respond rapidly to changing environmental cues. In the
developing axon and dendrites, these decisions are made at a
distance from the nucleus and so rely heavily on post-translational
mechanisms. The ubiquitin system regulates protein stability,
localisation and function in a rapid and quantitative manner and
has been shown to regulate multiple aspects of neural development
[1] [2] [3] [4]. Not surprisingly, given the precipitous conse-
quences of protein ubiquitylation, defects in the ubiquitin system
have been linked to a range of neurodevelopmental and
neurodegenerative diseases [5] [6] [7] [8] [9]. Specificity in the
ubiquitin system is imparted by the hundreds of E3 ubiquitin
ligases and deubiquitylating enzymes (DUBs), which add or
remove ubiquitin, respectively. DUBs function downstream in the
ubiquitin pathway, thus having the potential to act as final arbiters
of protein substrate fate and function [10] [11] [12]. Several
studies have shown that DUBs play important roles in the growth,
function and maintenance of neurons and synapses [13] [14,15].
Ubiquitin specific protease 9, located in the X chromosome
(Usp9x, also called FAM), is a substrate-specific DUB that is highly
expressed in the developing CNS in both humans and mice [16–
19]. Although Usp9x expression decreases in the mature CNS it
remains strongly expressed in the neurogenic regions including,
the sub-ventricular zone of the lateral ventricles and the sub-
granular zone cells of the dentate gyrus [17,20]. Usp9x function
has been implicated in several aspects of CNS development.
Increased expression of Usp9x in embryonic stem cell-derived
neural progenitors promotes their organisation into polarised
clusters, and increases their self-renewal and cellular potency [17].
In Drosophila, Usp9x’s homologue, fat facets (faf) regulates
photoreceptor fate as well as synaptic morphology and function
[13,21]. In humans USP9X has been implicated in lissencephaly
and epilepsy [16] and is an X-linked Intellectual Disability
candidate gene [22].
Usp9x is a large DUB (2554 amino acids) and several of its
substrates regulate aspects of neural development and/or homeo-
stasis. These include components of neurodevelopmental signal-
ling pathways such as Notch [23–25], Wnt [26] and TGF-b [27].
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In the Notch pathway Usp9x regulates the trafficking accessory
protein Epsin [28], as well as the ubiquitin ligase Mind Bomb1
[29] [30] in the signal sending cells. Usp9x also stabilises the Notch
intracellular domain E3 ligase, Itch [31], which functions in the
signal receiving cell [23,25]. Usp9x directly binds and stabilises b-
catenin, a component of cell-cell adhesion and a Wnt signalling
pathway second messenger, in a range of the mammalian cells and
tissues, including the CNS [26,32,33] where it is required for
proper development [34–36]. Usp9x deubiquitylation of Smad4 is
essential for signalling by members of the Tgf-b family [27,37].
Still other Usp9x substrates regulate neural progenitor adhesion
and proliferation. Acute lymphoblastic leukemia-1 fusion partner
from chromosome 6 (AF-6) is essential for the establishment of
adherens junctions and polarity in neural progenitor cells [38,39].
Usp9x regulates both the stability and localisation of AF-6 [40]
[41]. Another Usp9x substrate, Activator of G protein Signalling 3
(AGS3) is involved in spindle orientation and asymmetric cell
division in cortical progenitors [42] [43]. Finally, Usp9x binds the
microtubule-associated protein Doublecortin (DCX), which is
involved in neuronal migration, protein sorting and vesicle
trafficking [16] [44]. The interaction between Usp9x and DCX
is clearly important for human CNS development as patients with
point mutations in DCX that cannot bind Usp9x, develop
lissencephaly [16].
The above evidence suggests that there are ample avenues
through which Usp9x might regulate CNS development. Howev-
er, there are two significant caveats to implying a role for Usp9x in
neural development in vivo based simply on the observed substrate
associations. These are, (i) most of the Usp9x-substrate interactions
and regulation have been determined in cultured cells; (ii) whether
or not Usp9x is the rate-limiting determinant of a substrate’s fate,
and any subsequent developmental consequences, is largely cell
context-specific. Therefore, to assess the requirement for Usp9x
during mammalian CNS development we conditionally deleted
the Usp9x gene in neural progenitors using tissue-specific Cre
recombinase gene expression. Loss of Usp9x in all neural progenitors
resulted in early post-natal lethality, and was associated with
disorganised cortical architecture and reduced corpus callosum
and hippocampal volumes. More detailed analysis of neurons
revealed neurite growth defects that can, in-part, be explained by
refractory responses to TGFb stimulation. The results demonstrate
novel roles for Usp9x in brain development.
Materials and Methods
Ethics Statement
All experiments were performed under ethical clearance from
the Griffith University, and The Women’s and Children’s Health
Network, and the South Australian Pathology Department Animal
Ethics Committees. The research was conducted in accordance
with the policy and guidelines of the National Health and Medical
Research Council of Australia. Animals were monitored for signs
of pain and distress, all euthanasia was performed using cervical
dislocation, and all efforts were made to minimize suffering.
Generation of Usp9xloxP Mice
Usp9xloxP mice were generated by Ozgene Pty Ltd, Bentley,
Australia, as described [45]. Briefly, loxP sites were incorporated
into the second and third introns flanking exon three. Initiation of
translation occurs in exon two, followed by 96bps of coding
sequence. Deletion of exon three (146 bp), which contains an
incomplete number of codons, would result in a frame shift with
the next six alternative ATG start codons out of frame. To assess if
any translation occurred from an in frame start codon downstream
of exon three, an antibody raised against the USP9X C-terminal
was used.
Deletion of Usp9x in the Developing Mouse Brain
Usp9xloxP/loxP female mice were crossed with Nestin-Cre [46] or
Emx1-Cre [47] males, to delete Usp9x from the whole brain (Nestin-
cre) or dorsal telencephalon (Emx1-cre), respectively. Using this
breeding scheme Usp9x would be deleted from males, which
inherited Cre recombinase and in this gender result in a Usp9x null
genotype. Cre-negative male littermates were used as negative
controls in all experiments, except where noted. Cre-positive
female offspring are heterozygous for Usp9x gene deletion.
For all analyses a minimum of three or more Usp9xcKO/Y mice
versus three or more littermate controls were used. Results were
assessed statistically using a Student’s t test unless otherwise
specified.
Mouse Genotyping
DNA was extracted from neural tissues (brain or spinal cords)
and PCR was performed using standard techniques. Primers were
designed to detect Cre-recombinase: for 59-TGATGAGGTTCG-
CAAGAACC, rev 59-CCATGAGTGAACGAACCTGG. Male
embryos were identified using primers for the Sry region of the Y
chromosome: for 59-GAGGCACAAGTTGGCCCAGCAG, rev
59-GGTTCCTGTCCCACTGCAGAAG. Usp9x primers: for 59-
GCTCACCATTAGGTTGTTAG, rev 59-TAGACCCATCAT-
GAACCATG. Usp9x primers detect wild type Usp9x (505 base
pairs) as well as the Usp9xloxP gene with exon three removed R
Usp9xcKO/Y (207 base pairs).
Reverse Transcription-PCR Analysis
Total RNA was extracted from brains or testes using TRIzol
reagent (Invitrogen). Total RNA was treated with DNase I
(Invitrogen) then subjected to a mRNA purification step using a
MicroPoly(A) Purist mRNA purification kit (Ambion). Reverse
Transcription was performed using SuperScript III Reverse
Transcriptase primed with oligo(dT) (Invitrogen). PCR was then
performed on cDNA using standard techniques. Usp9y primers: F
59-ATGGCAGGTTGCACATTCAC, R5’-GTCTTCAT-
TACCCTGCAAGATC. qPCR reactions on RNA isolated from
hippocampal neurons were generated using the iTaq SYBR Green
Supermix (Biorad), run on the StepOne Plus Real Time PCR
System and analysed using StepOne Sortware V2.0 (Applied
Biosystems). Primers include; Bdnf F: ACTGGCTGACACTTTT-
GAGC, R: GCGTCCTTATGGTTTTCTTCG; Hes1 F: AAT-
GACTGTGAAGCACCTCC R: GTTCATGCACTCGCT-
GAAGC; EphB2 F: GTTGTATCTCAGATGATGATGG R:
GTCAAACCTCTACAGACTGG; Runx1 F: TCTGCA-
GAACTTTCCAGTCG R: GAGATGGACGGCAGAGTAGG.
Western Blot Analysis of Brain Tissue
Protein was extracted from embryonic and adult brain tissues
and Western blots were performed as described previously [33].
Signal was detected using horseradish peroxidase-conjugated
secondary antibodies (Millipore) developed with Immobilon
Western Chemiluminescent HRP Substrate (Millipore) then
imaged on a VersaDoc 4000 MP Imaging System (BioRad).
Histology and Immuno-fluorescence on Brain Sections
For analysis of embryonic brains, samples were drop fixed in
4% paraformaldehyde. For adult brains animals were anesthe-
tized, perfused trans-cardially with 4% PFA then heads were drop-
fixed in 4% PFA. Following fixation brains were processed for
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paraffin or cryo-sectioning using standard techniques and
sectioned at 10 mm. Histological analyses were performed using
standard cresyl violet (Nissl) staining. Hippocampal area was
calculated using SPOT software (Diagnostic Instruments Inc). The
hippocampal area of the first control was designated 100. The
hippocampal areas of all other controls and Usp9xcKO/Y mice were
converted to ratios compared to the first control. For immuno-
fluorescence brain sections were blocked with normal donkey
serum (Invitrogen), incubated overnight at 4uC with primary
antibodies, then incubated for 3 h at room temperature with
secondary antibodies and mounted with Vectashield mounting
medium with DAPI (Vector Laboratories). Images were obtained
on a AxioImager Z1 microscope (Carl Zeiss) or Olympus FV1000
confocal microscope. For coronal analysis, sections from a
comparable position along the rostral-caudal axis were used
[48]. Sections were matched by counting the number of coronal
sections starting at the rostral-most edge of the brain and
confirmed by closely matching any unchanged anatomical land
marks [49].
Neuronal Cell Assays
For hippocampal-derived neuronal cultures, embryos were
harvested at E18.5 and hippocampal neurons isolated and
cultured as previously described [50]. For morphometric analysis,
isolated cells were transfected with pMAX-EGFP using the mouse
neuron nuclefector kit according to the manufactures instruction
(Lonza). Cells were fixed with 4% PFA and immuno-fluorescence
was performed as previously described [50]. Images were
generated on an Axioplan2 microscope (Carl Zeiss). Axons and
dendrites were identified using Tau1 and MAP2 immuno-
reactivity respectively, and measured using ImageJ software
(National Institute of Health). Only neurites10 mm in length or
longer were included. For neurite growth kinetic analysis
Usp9xcKO/Y cultures from five different embryos were compared
with littermate control cultures from four different embryos. At
least twenty neurons were analysed per culture. For neurite growth
in response to TGFb signalling, day 3 cultures were supplemented
with 1 ng/ml TGFb (eBioscience) and cultured for 48 hours
before fixation and analysis. Cultures were derived from 3
different Usp9xcKO/Y embryos and 3 different littermate control
embryos. At least 20 neurons were scored in each culture. For
transcriptional response to TGFb signalling, day 3 pooled cultures
derived from 3 Usp9xcKO/Y embryos and 3 littermate embryos were
treated with 1 ng/ml TGFb for 48 hours and RNA analysed by
qRT-PCR as described above. Technical triplicate reverse
transcriptase reactions were analysed. For TGFb luciferase
reporter assays, isolated neurons were co-transfected with 5 ug
of the SMAD3/4 reporter construct pGL3-CAGA-Luc [51]; Kind
gift of Dr Hong-Jian Zhu, University of Melbourne) and 50 ng
pGL4.74-Renilla (Promega) using nucleofection as previously
described. This experiment was conducted on cultures isolated
from 5 Usp9xcKO/Y embryos and 5 control littermates grown in
duplicate. Following 2 days of culture, 0–10 ng/ml TGFb was
added to the media for 24 hours. Each culture was lysed and
analysed in technical triplicate using the Dual Luciferase Reporter
Assay System as per manufactures instructions (Promega). Control
experiments were conducted using un-transfected cells, and cells
transfected with Renilla or Luciferase only. All graphs display mean
average of replicate experiments, error bars represent standard
deviations, and statistically analysed using students unpaired 2-
tailed t-test, a p-value of less than or equal to 0.05 was considered
significant.
Primary Antibodies
Rabbit (Rb) anti-USP9X (Bethyl Laboratories A301-351A), Rb
anti-GapDH (R&D Systems 2275-PC-100), Rb anti-NF160
(Abcam ab9034), Chicken (Ck) anti-MAP2 (Millipore AB15452),
Mouse (Ms) anti-Tau1 (Millipore AB1512), Ms anti-MAP2
(Sigma-Aldrich M 1406), Rb anti-GFAP (DakoCytomation
Z0334), Ck anti-MAP2 (Chemicon), Ms anti-04 (Millipore
MAB345), Rb anti-Cleaved caspase-3 (Cell Signaling Technology
9661), Rb anti-DCX (Abcam ab18723), Rabbit anti-BLBP
(Millipore ABN14).
Secondary Antibodies
Dk anti-rabbit Alexa-Fluor 594 (Invitrogen), Dk anti-mouse
Alexa-Fluor 647 (Invitrogen), Dk anti-chicken Cy3 (Jackson
Laboratories), Dk anti-mouse Alexa-Fluor 488 (Invitrogen), Gt
anti-rabbit HRP (Millipore).
Results
Deletion of Usp9x from the Developing CNS Results in
Perinatal Lethality
As Usp9x is required for pre-implantation mouse embryo
development [41], in order to study Usp9x’s role in brain
development we generated Usp9xloxP/loxP females and bred them
with heterozygous males expressing Cre recombinase from the
Nestin promoter-enhancer, which is active in all CNS neural
progenitors from E10.5 [52]. Using this strategy, males that
inherited the Nestin-Cre transgene, would be potentially Usp9x null
(hereafter referred to as Nes-Usp9x2/Y mice). In preliminary studies
using mouse ES cells in vitro, we had established that activation of
Cre resulted in the loss of Usp9x exon3 and the Usp9x protein (data
not shown). The efficiency of Usp9x exon3 and protein deletion in
the brain in vivo was initially evaluated in E18.5 Usp9x2/Y embryos
(Figure S1A,B) by PCR and immunoblot using a C-terminally
targeted Usp9x antibody (Figure S1B). Immunoblots using an
antibody against the N-terminal 20 amino acids of Usp9x showed
a similar reduction in full-length (290kDa) Usp9x levels (data not
shown). We observed some residual full-length Usp9x protein, but
this was likely due to blood vessels and brain meninges that were
present in the samples [53] [54] [52]. Immunofluorescence
analyses detected very low, residual levels of Usp9x protein in
neural cells in E12.5 embryos (n = 4) and confirmed complete loss
of Usp9x protein in Nes-Usp9x2/Y embryos by E14.5 (n = 4
embryos) (Figure S.1 C–F).
Nestin-Cre mediated loss of Usp9x throughout the brain resulted
in early postnatal lethality. Of 154 pups analyzed, from 18 litters,
all Nes-Usp9x2/Y male mice died within 24 hours of birth.
Although Nes-Usp9x2/Y males could move at birth, were pink
and appeared to breathe normally, they failed to suckle, as
evidenced by lack of milk in their stomachs at the time of death.
Female offspring, heterozygous for the knockout of Nes-Usp9x
(Usp9x2/X), appeared normal at birth and survived to adulthood at
rates similar to wild-type females.
Usp9x has a homologue on the Y chromosome, Usp9y. Although
Usp9y is reported to only be expressed during spermatogenesis in
the mouse [55], we performed RT-PCR on P0 mouse brains to see
if its expression is induced following the deletion of Usp9x. We
failed to detect Usp9y expression in these brains indicating that it is
not induced and potentially compensating for some Usp9x
functions (Figure S2).
Loss of Usp9x Results in Reduced Neuronal Processes
Analysis of E16.5 to E18.5 brains failed to detect a significant
decrease in the size of Nes-Usp9x2/Y brains and low power
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histological analysis revealed that all major CNS regions were
present in the absence of Usp9x (not shown). However Nissl
staining revealed a general disorganization of the brain architec-
ture. The most obvious was the loss of a clear demarcation
between the neural progenitors in the ventricular and subven-
tricular zones and the neuroblasts of the intermediate zone in
E16.5 embryos (Fig. 1A–D) and E17.5 (not shown). These
observations were confirmed in E18.5 embryos where the neural
progenitor and radial glial markers Nestin and Brain Lipid
Binding Protein (BLBP) were more diffusely localized and
disorganized in Usp9x2/Y embryos (Fig. 1E,H). The neurons of
the cortical plate were also less densely packed in the absence of
Usp9x (Fig. 1I,J).
We next sought to determine the affect of Usp96 loss on
neurons and glia by staining for NF160 and GFAP, respectively. In
the absence of Usp9x we detected a dramatic reduction in the
number and length of NF160-positive neuronal processes. This
was most evident in those projecting from the entorhinal cortex
towards the hippocampus (Fig. 2A,B). GFAP staining was reduced
in size in the hippocampus and did not extend as far medially in
the cerebral cortex in E18.5 embryos (Fig. 2C,D). Within the
dentate gyrus of the hippocampus GFAP stained projections were
not as extensive in the absence of Usp9x (Fig. 2C–F).
As Nes-Usp9x2/Y mice die at P0, to study the effects of Usp9x
depletion on post-natal stages of brain development we mated
Usp9xloxP/loxP females to heterozygous Emx1-Cre males, where Cre
expression is restricted to the neural progenitors of the dorsal
telencephalon from E9.5 onwards [56]. Loss of almost all the
dorsal telencephalon is compatible with survival [57] and indeed
Emx1-Cre mediated Usp9x knockout mice (referred to as Emx1-
Usp9x2/Y hereafter) survived into adulthood. In an attempt to
generate Emx1-Usp9x2/2 females we paired four adult Emx1-
Usp9x2/Y males with eight Usp9xloxP/loxP females over a period
spanning four months, however, no litters were produced.
Therefore, Emx1- Usp9x2/Y mice fail to produce viable offspring.
In Emx1-Usp9x2/Y mice, Emx1-Cre activity resulted in loss of
Usp9x protein from the telencephalon (Figure S5). As observed in
Nes-Usp9x2/Y embryos, the neocortex of Emx1-Usp9x2/Y mice had
reduced neuronal processes projecting through the entorhinal
cortex towards the hippocampus (not shown). In adult (7–8 wk
old) Emx1-Usp9x2/Y mice NF160 immunoreactivity detected
aberrant neuronal processes (Fig. 3 A,B). In the absence of Usp9x,
NF160-immunoreactive processes were much thicker and pre-
dominantly projected toward the pial surface (top of image), rather
than ventricle (Fig. 3A,B). Aberrant processes were found in all
cortical layers. The localisation of the dendritic marker MAP2 was
similar in the presence or absence of Usp9x. However while the
MAP2 and NF160 stains did not overlap in control littermates
they partially co-localised in the thick pial-orientated projections in
Emx1-Usp9x2/Y brains (Fig. 3C–F).
The corpus callosum is the major axonal tract connecting the
two cerebral hemispheres. Analysis of the corpus callosum, from its
most rostral to caudal aspects, revealed a reduction in the dorso-
ventral thickness in Emx1-Usp9x2/Y mice (Fig. 4A–F). These data
suggest that Usp9x is required for the growth of axon tracts in the
brain.
Usp9x binds Doublecortin (Dcx) protein which is important for
neuronal migration in the human cortex [58]. Loss of Usp9x
however, in both Nes-Usp9x2/Y (E12.5– E18.5) and Emx1-Usp9x2/
Y (P7) mice did not affect the overall localization or level of Dcx in
the developing cerebral cortex (Figure S3).
Deletion of Usp9x Results in Reduced Hippocampal Size
Loss of Usp9x in the forebrain also dramatically affected the size
of the hippocampus. Analysis of hippocampal area from matched
sections detected a 74% reduction in hippocampal area in adult
Emx1-Usp9x2/Y mice (Fig. 5A–C). A similar degree of reduction in
the absence of Usp9x was evident from the most rostral to caudal
aspects of the hippocampus. We also analysed the hippocampi of
adult Emx1-Usp9x2/X heterozygous females and detected a
reduction of hippocampal area, though to a lesser extent (data
not shown).
Despite the reduction in size, most regions of the adult
hippocampus retained their relative organisation and cytoarchi-
tecture. However the cytoarchitecture of the CA3 region of the
stratum pyramidale was particularly affected (Fig. 5 D–F). There
was a significant thinning of the CA3 region in Emx1-Usp9x2/Y
mice (48.51+/20.21 mm SEM (Usp9x+/Y, n = 6); 21.95+/
26.43 mm SEM (Emx1-Usp9x2/Y, n = 5, p = 0.011)). There were
no significant alterations in the thickness of CA1 or CA2 areas, or
within the granular cell layers of the dentate gyrus in Emx1-
Usp9x2/Y mice (data not shown). A less severe reduction in
hippocampal size was already apparent in E17.5 and E18.5
embryos (data not shown).
A reduction in cell number may result from decreased
proliferation, increased apoptosis or a reduction in the migration
of neurons or glia within the hippocampus during development.
Analysis of apoptosis by staining for cleaved caspase-3 [48] (Figure
S4.) revealed that loss of Usp9x increased apoptosis in the
hippocampus and medial neocortex at E18.5 and P0 (Usp9x+/
Y=1.1+/21.1 cells (n = 9) versus Usp9x2/Y 5.9+/25.1 cells,
n = 10; p= 0.013).
Deletion of Usp9x Results in Reduced Axonal Elongation
and Tgf-b Response in vitro
To determine if reduced axon length was due to cell
autonomous effects of Usp9x, we cultured hippocampal neurons
in vitro and measured both neurite length and branching. [59].
Cultured Nes-Usp9x2/Y hippocampal-derived neurons displayed
both reductions in primary axonal length and in the number of
axonal and dendritic termini, which reflects their degree of
arborisation (Fig. 6). At day 3 of culture, Usp9x2/Y axons were
30% shorter than control axons, whilst by day 7 of culture this
difference had reached 44% (Fig. 6B). Likewise, the total number
of neurite termini was reduced by 28–36% across all days of
culture, and whilst the reduction in axonal termini number was the
predominant contributor to this result (with reductions ranging
between 43–53%), reductions in dendritic termini were also
observed (Fig. 6C). Given the low cell density in these experiments
the data strongly suggest that Usp9x function is required cell
autonomously for the initiation and/or elongation of neurites,
which supports our in vivo observation.
Usp9x is a major regulator of the Tgf-b family signalling
pathway due to its deubiquitylation and hence activation of, the
common Smad protein, Smad4 [27,37]. Recently, Tgf-br2 has
been shown to be important for axon initiation and elongation
[60], whilst it is well established that supplementing cultured
neurons with TGFb increases axonal growth [61]. Therefore we
sought to determine if loss of Usp9x affected Tgf-b signalling in
neurons (Fig. 7). To test the status of Tgf-b signalling in the
absence of Usp9x we transfected hippocampal neurons with a Tgf-
b-luciferase reporter construct [51]. We detected 2.6-fold higher
basal levels of luciferase activity, normalised against renilla
expression in the absence of Usp9x (Fig. 7A). However, while
wild-type neurons could respond to increasing concentrations of
Tgf-b with higher luciferase activity, there was no change in the
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Figure 1. Loss of Usp9x disrupts the architecture of the embryonic neocortex. The Nestin-cre mediated deletion of Usp9x (B,D) results in
loss of demarcation between the cells of the ventricular and sub-ventricular zones (VZ/SVZ), the more disperse cellular density of the intermediate
zone (IZ) and the neurons of the cortical plate (CP) seen in control littermates (A,C). C and D are higher magnification images of A and B, respectively.
Nestin (E,F) and BLBP (G,H) staining in E18.5 embryos indicated that neural progenitors were more loosely organized in the VZ/SVZ. Neurons of the
Usp9x Regulates Brain Development
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absence of Usp9x (Fig. 7B). This difference was greatest in the
presence of 10 ng/ml TGFb, resulting in a 3.3 fold elevation of
luciferase activity relative to basal levels in control neurons,
compared to only a 1.3 fold elevation in Usp9x2/Y neurons. This
suggested that Usp9x is required in neurons to respond to Tgf-b.
We next measured the mRNA levels of putative Tgf-b target genes
in response to 1 ng/ml Tgf-b in the presence and absence of
Usp9x. The TGF-b target gene Bdnf [62] showed no response to
Tgf-b in the absence of Usp9x. Bdnf acts as a self-amplifying
autocrine factor to promote axon formation and growth in
hippocampal neurons [63]. Paradoxically, Runx1 showed a higher
response to Tgf-b in the absence of Usp9x. However as Runx1
responds to TGF-b in a Smad4-independent manner [64] it might
not be affected by the absence of Usp9x which deubiquitytes
Smad4. The other putative target genes assayed, b-catenin, Ephb2
and Hes1 did not respond to Tgf-b. Finally we measured the
response of axon growth and neurite arborisation to 1 ng/ml Tgf-
b exposure following 5 days of culture. Consistent with previous
reports [61] we detected an 49% increase in axonal length in wild
type neurons in response to Tgf-b. In comparison, only a
negligible increase (14%) in axonal length was detected in
Usp9x-null neurons (Fig. 7D). Likewise, whilst the number of
neurite termini was increased by 40% in response to Tgf-b in
control neurons, again predominately because of increases in
axonal branching, no such response was observed in cells lacking
Usp9x (Fig. 7C). These data establish that axon growth in
cortical plate were disorganized in the absence of Usp9x (J) compared with littermates (I). Nissl stain of Usp9x+/Y (A,C,G) and Usp9x2/Y (B,D,H) in E16.5
embryos (A–D, G–H). V = ventricle. Scale bar = 100 mm (A), 50 mm (C), 40 mm (E), 100 mm (G), 40 mm (I).
doi:10.1371/journal.pone.0068287.g001
Figure 2. Usp9x loss affects neuronal and astrocytic projections. NF160 antibodies decorate axonal projection from the neocortex (Nc) to the
hippocampus (Hp) in E18.5 Nes-Usp9x+/Y mice (A). These projections were absent in Nes-Usp9x2/Y mice (B). GFAP staining is reduced in both the
hippocampus and neocortex of E18.5 Usp9x 2/Y embryos (D) compared with littermate controls (C). In the hippocampus GFAP-labeled projections
extended toward the CA3 region in control embryos (arrowhead in E) but not in the absence of Usp9x (F). Scale bar = 20 mm (A,B), 1606mm (C,D),
806mm (E,F).
doi:10.1371/journal.pone.0068287.g002
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hippocampal neurons requires Usp9x in order to respond to Tgf-
b. Loss of Usp9x did not affect the viability of the cultured
hippocampal neurons (Figure S6).
Discussion
Usp9x is highly expressed throughout the embryonic brain and
in specific regions of the adult brain including the neurogenic
zones [16,17]. To investigate whether Usp9x is required for neural
development and maintenance we deleted Usp9x in neural
progenitors of the developing brain using both a Nestin-Cre and
Emx1-Cre deletion strategy. Here, we report that loss of Usp9x in
the entire brain results in death within 24 hours of birth, possibly
due to a failure to suckle. Although the overall architecture of the
brain developed normally in the absence of Usp9x, its loss resulted
in reduction of the corpus callosum and hippocampal size. At
higher resolution, we revealed loss of Usp9x led to disorganisation
of the developing neocortex architecture, observed early within the
neural progenitor populations, and in the axonal projections of the
neurons of the cortical plate.
Our data show that during neuronal development Usp9x is
required for the correct development of CNS axons. The severe
reduction of the corpus callosum in Emx1-Usp9x2/Y mice is
consistent with this observation. To examine the molecular
mechanisms underlying the axonal defect we assessed Tgf-b
signalling capacity in cultured hippocampal neurons. The
rationale for this was based on two observations. First, Usp9x
regulation of Tgf-b signalling has been demonstrated in other
developmental systems, as diverse as Drosophila wing development
and dorsal-ventral patterning, the gastrulating Xenopus embryo,
and wound healing in human cells [27,37]. Usp9x regulation of
these systems is due to its deubiquitylation of the common Smad
protein, Smad4, which partners with receptor Smads to activate
Figure 3. Absence of Usp9x alters neuronal projections in the neocortex. NF160 staining of adult cerebral cortex (7–8 wk) Emx1-Usp9x+/Y
(A,C,E) and Emx1-Usp9x2/Y (B,D,F). NF160 stains thick, pial-oriented projections in Emx1-Usp9x2/Y mice (B). NF160 (red) colocalises with the dendritic
marker MAP2 (green) in the thick projections detected in Emx1-Usp9x2/Y cortical neurons (arrowheads in D,F). There is little overlap in control
littermates (C,E). Orientation is such that the pial surface (P) is to the top, and ventricle (V) to the bottom of each image. Scale bar = 30 mm (A), 406mm
(C,E).
doi:10.1371/journal.pone.0068287.g003
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Tgf-b family member target genes [65]. Cyclic ubiquitylation and
deubiquitylation of Smad4 by the E3 ligase Ectodermin and
Usp9x, respectively, regulates the nuclear/cytoplasmic shuttling of
Smad4 which is required for continued Tgf-b signalling in the
presence of ligand [27]. The second observation is that the Tgf-
brII receptor is required for axonogenesis in the mouse brain [60].
The axonal phenotype observed in these mice is similar to those in
our Usp9x null mice. Our data show that axons from hippocampal
neurons did not increase in length in response to exogenous Tgf-b
in the absence of Usp9x. In addition, a Tgf-b reporter construct
and the endogenous target gene Bdnf, did not respond to
increasing TGF-b concentration in the absence of Usp9x (Fig. 7).
These data strongly suggest there is little Tgf-b signalling in
neurons in the absence of Usp9x explaining, at least in part, the
failure or delay in axon growth in Usp9x deleted brains. However,
Usp9x facilitation of Tgf-b signalling does not entirely explain our
observed phenotype. Deletion of Smad4 in the brain results in a
much milder phenotype than in the Usp9x2/Y mice [66]. In
addition, although Tgf-brII is required for axon development it
had no effect on dendrites, but dendritic development was also
impaired in the absence of Usp9x, at least in vitro (Fig. 4) suggesting
Usp9x regulates other critical substrates during CNS development.
In addition to its requirement during axonal development, loss
of Usp9x also affected the localisation of the axonal protein NF160
in the forebrain of adult Emx1-Usp9x2/Y mice. In a number of
neurons NF160 co-localised with the dendritic marker MAP2 in
thick processes projecting toward the pial surface (Fig. 4). This
may reflect inappropriate trafficking of NF160 to dendrites, and
Usp9x has been implicated in the trafficking of proteins in a
polarised manner [33,67]. Alternatively, the mis-localisation of
NF160 may reflect a more general loss of polarity in Usp9x null
neurons. The earliest consequence of Usp9x loss was disorgani-
Figure 4. Loss of Usp9x results in reduction of the corpus callosum. Nissl staining of matched sections showing thinning of the corpus
callosum In Emx1-Usp9x2/Y adults males (C,D) compared with Emx1-Usp9x+/Y littermates (A,B). NF160 staining revealing reduction of the corpus
callosum is evident in Emx1-Usp9x2/Y P8 mice (E,F). (n = 4 for both Emx1-Usp9x2/Y and Emx1-Usp9x+/Y littermates). Scale bar = 160 mm (A), 200 mm (E).
doi:10.1371/journal.pone.0068287.g004
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sation of neural progenitors in the VZ/SVZ of the neocortex
observed in Nissl-stained sections and the tangled organisation of
nestin and BLBP (Fig. 1). Usp9x regulates a number of cell
adhesion and polarity proteins in polarised epithelial cells and
increased expression of Usp9x enhances the polarised organisation
of neural progenitors in vitro [17]. We have identified a number of
Figure 5. Usp9x is required for hippocampal development. The hippocampi of adult Emx1-Usp9x2/Y mice (B) were reduced in area compared
with Usp9x+/Y littermates (A). Nissl stain of 7–8week old mice. (C) Quantification of hippocampal area of Usp9x+/Y adult males (Control, n = 4)
compared with Usp9x2/Y (cKO, n = 4) (** p,0.01). (D–F) Higher magnification identifying disruption and reduction of the CA3 region in Usp9x 2/Y
males. (D - Usp9x+/Y; E,F independent Usp9x2/Y males) Scale bar = 100 mm (A,B), 150 mm (D–F).
doi:10.1371/journal.pone.0068287.g005
Figure 6. Loss of Usp9x reduces neuronal outgrowth. Embryonic hippocampal neurons were isolated, transfected with a plasmid encoding
Enhanced Green Fluorescent Protein, and grown in-vitro for 3, 5 or 7 days. (a) Example immunofluorescent images of wildtype (Nes-Usp9x+/Y) and null
(Nes-Usp9x2/Y) neurons resolved using GFP expression (Green) and co-stained with the axonal and dendritic specific antibodies, TAU1 (cyan) and
MAP2 (red) respectively. (b–c) Morphometric analysis was employed to record mean primary axonal length (b) and number of neurite termini (c).
*p,0.05 by student 2-tailed t-test.
doi:10.1371/journal.pone.0068287.g006
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cell adhesion and polarity complex proteins mis-localised or mis-
expressed in Usp9x null neural progenitors (SP, SAW in
preparation). These early effects may have ramifications for later
developmental events such as axon elongation.
Loss of Usp9x also reduced the size of the hippocampus by 75%
(Fig. 5). Hippocampal reduction was observed at late embryonic
stages though not as severe as in the adult. An increase in apoptosis
was observed in E18.5 and P0 Emx1-Usp9x2/Y in the hippocampal
region and may, in part, contribute to the reduction. A potential
candidate mediating this effect is the anti-apoptopic protein Mcl1,
which can be stabilised by Usp9x, at least in lymphoma and
cultured cell lines [68]. However, deletion of Mcl1 results in a
more severe loss of neural cells throughout the entire CNS.
Therefore Usp9x may only be a rate-limiting factor of Mcl1 levels
in the hippocampus. The hippocampal phenotype, in particular
the reduction in size, disorganisation of the CA3 region, together
with the absence or reduction of the corpus callosum, is similar to
that observed in Doublecortin (Dcx) and Doubelcortin-like (Dckl)
double knock-out mice [69]. Dcx is an Usp9x interacting protein,
though not a substrate, as it is not ubiquitylated [16]. Instead it is
proposed that Dcx traffics Usp9x along axonal microtubules. A
mutation in Dcx, which is unable to bind specifically to Usp9x,
was detected in a patient with lissencephaly, suggesting this
interaction is important in human cortical development [16].
Given the similarity in phenotype in the mouse knockout models,
it may be that Usp9x is also required for the migration of
hippocampal neurons, especially those destined for the CA3
region. The disorganisation of nascent neurons in the cortical plate
in embryonic cerebral cortex (Fig. 1) also supports a role for Usp9x
in neuronal migration. However, this may be independent of Dcx
as its expression was not altered in the cerebral cortex in the
absence of Usp9x (Figure S3).
The Bmp and Wnt signalling pathways at the cortical hem in
the medial neocortex are essential for the development of the
hippocampus [70,71]. As a member of the Tgf-b family of
signalling proteins, Smad4 is required in the signal-receiving cell to
facilitate Bmp signalling. As noted above Usp9x neurons did not
respond to Tgf-b raising the possibility that defective Bmp
signalling may contribute to the reduction in hippocampal growth
as has been suggested [72]. Usp9x can also stabilise b-catenin,
which is a second messenger for the canonical Wnt signalling
pathway. Therefore Wnt signalling may also be defective in the
hippocampal anlage. A more detailed analysis of Usp9x regulation
of hippocampal development is required.
USP9X has already been linked to a number of human
neurodevelopmental and neurodegenerative disorders. USP9X is
linked to lissencephaly, via its interaction with DCX [16], and
USP9X is a candidate gene in X-linked intellectual disability and
Figure 7. Loss of Usp9x disrupts TGF-b signalling in hippocampal neurons. (a–b) TGF-b luciferase reporter assays conducted in either
wildtype (Nes-Usp9x+/Y) or null (Nes-Usp9x2/Y) embryonic hippocampal neuronal cultures. Hippocampal neurons were isolated and transfected with
both renilla control and pGL3-TGF-b luciferase reporter plasmids. (a) Cells were grown for 3 days before analysis using dual-luciferase reporter assays
and data normalised relative to wildtype readings. (b) Luciferase reporter activity in response to increasing concentrations of TGF-b. Data normalised
to controls in the absence of TGF-b. All luciferase data from 6 biological replicates (i.e. cultures isolated from 6 Usp9x+/y and 6 Usp9x2/Y embryos). (c)
Response of established TGFb target genes in presence or absence of Usp9x, analysed by RT-qPCR. Isolated hippocampal neurons grown for 2 days
prior to the addition of 1 ng/ml TGF-b. (d–e). Morphological analysis of hippocampal neurons exposed to 1 ng/ml TGF-b in the presence or absence
of Usp9x. (d) Comparison of mean primary axonal length. (e). Comparison of number of neurite termini.
doi:10.1371/journal.pone.0068287.g007
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epilepsy [22]. Usp9x also deubiquitylates mono-ubiquitylated
alpha-synuclein raising the possibility it may play a role in the
progression of neurodegenerative diseases such as Parkinson’s
disease [73]. This study indicates that Usp9x regulation of brain
development likely involves multiple pathways and elucidation of
these mechanisms may shed light on a number of human
conditions involving aberrant neural development and/or func-
tion.
Supporting Information
Figure S1 Deletion of Usp9x exon 3 and protein in Nes-
Usp9x2/Y embryos. (A) PCR detected removal of exon 3 in
genomic DNA isolated from Nes-Usp9x2/Y E18.5 embryos. (B)
Immunoblot analysis of whole brain lysate revealing decreased
levels of Usp9x protein in E18.5 Nes-Usp9x2/Y embryos identified
by PCR. Residual levels of full length Usp9x probably reflect the
presence of non-neural cells in brain lystates. (C–F) Usp9x
antibody staining of neocortex of E12.5 (C,D) and E14.5 (E,F)
wild-type (Nes-Usp9x+/Y; C,E) and knockout (Nes-Usp9x2/Y; D,F)
embryos. Residual amounts of Usp9x was detected in E12.5 Nes-
Usp9x2/Y neural tissue (D), but Usp9x was unable to be detected
by E14.5 (F). Representative images from n= 4 for each genotype
at each embryonic stage.
(TIF)
Figure S2 Usp9y expression is not induced in the
absence of Usp9x. RT-PCR failed to detect Usp9y transcripts
in P0 brains in Usp9x+/Y (WT), Nes-Usp9x2/Y (cKO) of female (F)
pups. Usp9y was detected in RNA isolated from adult mouse testis
(T). Beta-actin transcripts were detected in all samples.
(TIF)
Figure S3 Loss of Usp9x does not affect Doublecortin in
the developing cerebral cortex. Immunofluorescence staining
of Doublecortin (Dcx) in the presence (A,C,E,G,I) or absence
(B,D,F,H,J) of Usp9x. At each stage three Usp9x+/Y and three
Usp9x2/Y littermates were compared. Representative images are
shown. Embryos from Nes-Usp9x matings (A–H) and pups
(postnatal day 7, P7) from Emx1-Usp9x matings were analyzed.
LV= lateral ventricle. Scale bar = 100 mm.
(TIF)
Figure S4 Loss of Usp9x increases neural apoptosis.
10 mm coronal cryosections of medial neocortex from E18.5 Nes-
Usp9x embryos stained with antibodies to cleaved caspase 3 (red) to
identify cells undergoing apoptosis. Nuclei are stained with DAPI
(blue).
(TIF)
Figure S5 Emx1-cre deletion of Usp9x. 10 mm coronal
cryosections of 7 week Emx1-Usp9x+/y (A,C) and Emx1-Usp9x2/y
(B,D) brains stained with Usp9x antibody (red) and DAPI (blue) to
detect nuclei. Usp9x is absent form the cerebral cortex (B) but
present at the same level in the striatum as control littermates
(C,D).
(TIF)
Figure S6 Loss of Usp9x does not affect the apoptosis of
cultured hippocampal neurons.Wildtype (Usp9x+/Y; n = 3) or
knockout (Usp9x2/Y; n =23) hippocampal neuronal cultures were
grown in-vitro for 8 days. A. Representative immunofluorescent
images showing cells stained for the apoptotic marker activated
caspase 3 (green), the neuronal marker bIII-tubulin (red) and cell
nuclei counterstained with DAPI (Blue). B. The percentage of
caspase3 positive (+ve) cells in wildtype and Usp9x null cultures. At
least 1000 cells were scored per experiment. p = 0.39 by Students
2-tailed unpaired t-test.
(TIF)
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